definiens: shall mean the diagnosis, p revention and treatment, through encapsulated cell therapy, of : 1.16.1 Diabetes ( other than the diagnosis, prevention or treatment of diabetes utilizing encapsulated primary islet c ells ) ; 1.16.2 Obesity ; 1.16.3 Anemia ; 1.16.4 The treatment of Hemophilia A or B t hrough the delivery of Factor VIII, Factor IX or both ; and 1.16.5 Two additional fields categories to be agreed to by CTI and Modex no later than June 30, 2003, each such field ca tegory to be specified by reference to a disease state or disorder and, i f applicable, the delivery of a specific substance or substances . Each of the additional field categories shall be specified by Modex, subject to the con sent of CTI, which 4 < PAGE > shall not be unreasonably withheld ( with the withho lding of any such consent based solely on the potential market share of such field category being deemed unreasonable ), provided, however, that CTI may, in its sole discretion, withhold consent to any Field category involving the treatme nt of any disease state or disorder of the [ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ] 1.17 . shall mean 1.17.1 CURRENT ENCAPSULATION KNOW - HOW . All Confidential Information of Modex owned by Modex or under which Modex has t he right to grant licenses to CTI in the CTI Field which constitutes Encapsul ation Technology as of the Restatement Date ( for so long as such Confident ial Information continues to be Confidential Information of Modex ) ; 1.17.2 FUTURE ENCAPSULATION KNOW - HOW . Any f uture Confidential Information of Modex owned by Modex or under wh ich Modex has the right to grant licenses to CTI in the CTI Field which co nstitutes Encapsulation Technology ( for so long as such Confidential In formation continues to be Confidential Information of Modex ) ; and 1.17.3 CURRENT CELL LINE KNOW - HOW . Certain additional Confidential Information regarding cells and cell lines owne d by Modex or under which Modex has the right to grant licenses to CTI in the CTI Field as of the Restatement Date, as more specifically describe d on Schedule 1.17.3 ( for so long as such Confidential Information continues to be Confidential Information of Modex )